The synthetic glycolipid-based TLR4 antagonist FP7 negatively regulates in vitro and in vivo haematopoietic and non-haematopoietic vascular TLR4 signalling

Overview of attention for article published in Innate Immunity, September 2018

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (63rd percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

twitter: 7 tweeters

Citations

dimensions_citation: 12 Dimensions

Readers on

mendeley: 21 Mendeley

Summary Twitter Dimensions citations

So far, Altmetric has seen 7 tweets from 7 users, with an upper bound of 14,527 followers.

New from #TheBHF https://t.co/W47hG4VXdP The synthetic glycolipid-based TLR4 antagonist FP7 negatively regulates in vitro and in vivo haematopoietic and non-haematopoietic vascular TLR4 signalling

22 Nov 2019

Reply Retweet Favourite

The synthetic glycolipid-based #TLR4 antagonist FP7 negatively regulates in vitro and in vivo haematopoietic and non-haematopoietic vascular TLR4 signalling. #BtBsPub https://t.co/obTfSCwJOK

22 Mar 2019

Reply Retweet Favourite

The synthetic glycolipid-based TLR4 antagonist FP7 negatively regulates in vitro and in vivo haematopoietic and non-haematopoietic vascular TLR4 signalling #InnateImmunity #OpenAccess https://t.co/jBZbqXODJN

09 Nov 2018

Reply Retweet Favourite

07 Nov 2018

Reply Retweet Favourite

This page shows the most recent tweets that mention this research output.

Click here to find out how to access more activity, including 3 additional tweets.